Clinical Trials Logo

Agitation clinical trials

View clinical trials related to Agitation.

Filter by:

NCT ID: NCT04266340 Completed - Agitation Clinical Trials

Different Premedication in Pediatric Patients

Start date: December 13, 2020
Phase: N/A
Study type: Interventional

The investigators studied the effects of intranasal dexmedetomidine compared with oral midazolam with different doses for premedication in children. One hundred and twenty children aged between 2 and 12 years were randomly allocated to one of four groups:2.5µg/kg intranasal dexmedetomidine group ; 0.5mg/kg oral midazolam group;0.05 mg/kg intravenous injection midazolam group; no premedication group. Sedation levels 10, 20, and 30min after premedication were evaluated using a 5-point sedation scale. A 4-point emotional state score was used to evaluate participators when they were separated from their parents and their response to intravenous cannulation or facemask application. Agitation scores (Pediatric Anesthe-sia Emergence Delirium [PAED] scale) and POV were assessed in the postanesthetic care unit (PACU).Times to endotracheal tube or laryngeal mask airway removal, discharge from the PACU and patients' satisfaction degree were also assessed.

NCT ID: NCT04039269 Recruiting - Behavior Clinical Trials

Long Term Memory Preoperative Preparation Reduce Post Operative Behavioral Change

Start date: December 2013
Phase: N/A
Study type: Interventional

The study is designed to test the hypothesis that long term memory created by preoperative video information can reduce the incidence of post operative behavioral changes.

NCT ID: NCT04010305 Completed - Schizophrenia Clinical Trials

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Start date: May 22, 2019
Phase: Phase 1
Study type: Interventional

This is a two-stage adaptive Phase Ib trial design, that will identify two doses (lowest dose with clinical benefit and highest safe dose) in a first stage and better evaluate safety, tolerability and variability of effect in the second stage.

NCT ID: NCT03773874 Completed - Pain Clinical Trials

Assessment of Analgesia, Sedation, Physical Restraints and Delirium in Spanish Intensive Care Units

ASCyD
Start date: February 12, 2018
Phase:
Study type: Observational [Patient Registry]

This study assess which Spanish intensive care units evaluate and record, in a standardized way, levels of pain, sedation / agitation, use of physical restraints and prevalence of delirium. Also determine the use of validated assessment tools and explore levels of pain and sedation / agitation, use of physical restraints and prevalence of delirium.

NCT ID: NCT03639558 Completed - Aggression Clinical Trials

TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting

TREC
Start date: August 28, 2018
Phase: Phase 4
Study type: Interventional

This is a randomised controlled trial comparing haloperidol + promethazine versus haloperidol + promethazine + chlorpromazine for agitated patients in the emergency department.

NCT ID: NCT03554915 Completed - Agitation Clinical Trials

Ketamine Versus Midazolam for Prehospital Agitation

Start date: August 1, 2017
Phase:
Study type: Observational

This research study is being done to figure out the best approach to treatment of pre-hospital agitation. It will compare two tiered dosing treatment protocols, one ketamine-based and one midazolam-based. Agitation is a state of extreme emotional disturbance where patients can become physically aggressive or violent, endangering themselves and those who are caring for them. Often chemical substances or severe mental illness are involved in this level of agitation. Specifically, the investigators are interested in studying agitation that is treated in the prehospital setting by paramedics. This study's hypothesis is a ketamine-based protocol will achieve a faster time to adequate sedation than a midazolam-based protocol for treatment of agitation in the prehospital environment. This study will observe the natural history of an emergency medical services standard operating procedure change from a ketamine-based protocol to a midazolam-based protocol.

NCT ID: NCT03398759 Recruiting - Agitation Clinical Trials

Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Emergence agitation is one of the common postoperative complications after functional endoscopic sinus surgery(FESS). The objective of present study is to explore the effectiveness of butorphanol in the alleviation of emergence agitation in patients undergoing Functional Endoscopic Sinus Surgery.

NCT ID: NCT03317067 Completed - Delirium Clinical Trials

Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)

4D
Start date: December 21, 2017
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to evaluate whether dexmedetomidine is effective in treating agitated delirium of non-intubated ICI patients

NCT ID: NCT03044249 Terminated - Dementia Clinical Trials

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Start date: May 4, 2017
Phase: Phase 2
Study type: Interventional

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

NCT ID: NCT02877108 Recruiting - Agitation Clinical Trials

Naturalistic Adasuve Clinical Trial Study

Start date: April 2016
Phase: Phase 1
Study type: Observational

There is limited information on the best psychoactive medication to treat agitated patients in the emergency department. The intent of this study is to fill in knowledge gaps in the current practice of treating psychiatric patients in the acute care setting. The purpose of this study is to determine the best treatment for agitated psychiatric patients in the emergency department.